enzh-TWfrdeitjaptrues
You are here: Home Publications Pub-2018 Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia

Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenström macroglobulinaemia

Legal | Privacy

Copyright © Bing Center for Waldenstrom's Macroglobulinemia 2000 - 2021